News for Read Beyond News
Pascal Soriot, head of AstraZeneca has been calling on the government for the purpose of providing access to the corona virus vaccine of AstraZeneca known as Evusheld and he said that, it has been a sad situation that, the United Kingdom has been one of the few developed nations, which
Read More
Huma Therapeutics Limited, a digital health technology company has announced partnership with AstraZeneca for the purpose of scaling the innovation of digital health. This partnership has been following the prior use cases have been executed between AstraZeneca and Huma has been reflecting a shared ambition for the purpose of improving
Read More
The pharmaceutical company ‘AstraZeneca’ said, the antibody-based cocktail of the company for the prevention and treatment of the novel corona virus had been showing to retain the neutralization activity against the Omicron corona virus variants that is including the highly contagious BA.2 sub variant of the Omicron in a study
Read More
The UK MHRA (Medicines and Healthcare products Regulatory Agency) has now granted the authorization to the Evusheld of AstraZeneca for the pre-exposure prophylaxis (PrEP) against the novel corona virus, and the Evusheld has been a cocktail of the two monoclonal long-acting antibodies, along with the cilgavimab and tixagevimab. The company ‘AstraZeneca’
Read More
On Thursday, 13th January 2022, AstraZeneca said that, the primary analysis of the ongoing immunogenicity and safety trial has now been indicating that, the Vaxzevria, when it has been given as the third corona virus vaccine booster dose, along with the increased response of the antibody to the Omicron corona
Read More
On 4th January 2021, the United Kingdom became the first country in the world for administering the novel corona virus vaccine developed by the Oxford University and AstraZeneca, and since then, around 50 million corona virus vaccines developed by the company ‘AstraZeneca’ have been administered in the United Kingdom, responsible
Read More
Prince Charles of the United Kingdom has been formally opening a new research and development (R&D) facility of AstraZeneca as the company has been aiming to fuel the growth of the drug pipeline of the company. AstraZeneca has also been supplying two billion doses of the novel corona virus vaccine that
Read More
On Monday, 1st November 2021, AstraZeneca said, it is going to be transferring the global rights for the respiratory medicines including Duaklir and Eklira to the Covis Pharma Group for a deal of 270 million dollars as AstraZeneca is looking to offload the company’s old portfolio of the medicines. The company
Read More
The company AstraZeneca has now submitted the company’s antibody cocktail for the emergency authorization of the United States for the purpose of preventing the novel corona virus infection as the options of therapeutic for the covid-19 pandemic. It has been the first regulatory filing for the medicine of the novel corona
Read More
On Wednesday, 30th September 2021, according to the US clinical trial, the novel corona virus vaccine developed by AstraZeneca has shown 74 percent efficacy at the prevention of the symptomatic disease, which has been a figure that has been increased to 83.5 percent in the people, who are above the
Read More